In order to further determine specific factors promoting the onset of DCM by regulating host inflammation, we first performed ELISA to determine protein expression levels of IL-1β, IL-6, IL-17, and TNF-α in the serum of diabetic patients (Supplementary Table S1). The gene discussed is IL17A; the disease is familial dilated cardiomyopathy.